Internal Medicine, Hematology & Oncology · Chicago, IL
NPI
1902910425
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
850 W Irving Park Rd
Chicago, IL, 60613
Phone (773) 975-6749
Groups this clinician bills Medicare through
Medicare paid, 2024
$270K
3,781 services
Medicare patients, 2024
303
Average age 73
Drug cost, 2024
$1.3M
2,399 prescriptions
Company payments, 2025
$2,950
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Manjeet S Chawla was code 99214 (office e&m - established), 2,975 times for 272 patients. In total Manjeet S Chawla billed 3,781 services in 11 codes, and Medicare paid $270K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 2,975 | 272 | $72.42 | $215K |
| 99232 Hospital E&M - Subsequent | Facility | 472 | 80 | $58.94 | $28K |
| 99222 Hospital E&M - Initial | Facility | 138 | 82 | $98.44 | $14K |
| 99238 Hospital Discharge Management | Facility | 111 | 60 | $60.46 | $6,712 |
| 99213 Office E&M - Established | Facility | 36 | 15 | $49.42 | $1,779 |
| 99204 Office E&M - New | Facility | 35 | 35 | $101.05 | $3,537 |
By year: 2022 $348K for 4,362 services; 2023 $277K for 3,469 services; 2024 $270K for 3,781 services.
Medicare prescription drug claims, 2024
In 2024, the drug Manjeet S Chawla prescribed most often to Medicare patients was Amlodipine Besylate, with 139 prescriptions and refills. In total Manjeet S Chawla wrote 2,399 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 139 | 383 | 55 | $506 |
| Pantoprazole Sodium Generic | 115 | 290 | 43 | $923 |
| Tramadol Hcl Generic | 82 | 82 | 19 | $379 |
| Anastrozole Generic | 79 | 231 | 25 | $1,151 |
| Metformin Hcl Generic | 66 | 180 | 21 | $220 |
| Simvastatin Generic | 59 | 165 | 19 | $264 |
| Bicalutamide Generic | 56 | 142 | 18 | $1,882 |
| Levofloxacin Generic | 52 | 52 | 44 | $153 |
| Triamterene-Hydrochlorothiazid Triamterene/Hydrochlorothiazid | 51 | 143 | 20 | $349 |
| Baclofen Generic | 48 | 50 | 17 | $632 |
| Lorazepam Generic | 48 | 50 | Under 11 | $124 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 47 | 47 | 29 | $301 |
| Metoprolol Succinate Generic | 46 | 127 | 20 | $556 |
| Celecoxib Generic | 45 | 52 | 24 | $2,297 |
| Metoprolol Tartrate Generic | 43 | 112 | 15 | $142 |
Brand drugs: - claims; generic drugs: 2,133 claims; opioid claims: 109.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Manjeet S Chawla $2,950 ($2,950 in general payments such as food, travel and fees) from 27 companies. The largest payer was Janssen Biotech, Inc. with $491.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 16 | $491 |
| GlaxoSmithKline, LLC. GSK | 13 | $275 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 9 | $235 |
| E.R. Squibb & Sons, L.L.C. BMY | 11 | $230 |
| Gilead Sciences, Inc. GILD | 9 | $217 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $215 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $170 |
| Lilly USA, LLC LLY | 7 | $161 |
| Genzyme Corporation SNY | 6 | $148 |
| Abbvie Inc. ABBV | 5 | $120 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.